Showing 1 - 5 results of 5 for search 'Uriel Rumbo-Nava', query time: 0.03s
Refine Results
-
1
IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung Adenocarcinoma by Lorenzo Islas-Vazquez, Dolores Aguilar-Cazares, Miriam Galicia-Velasco, Uriel Rumbo-Nava, Manuel Meneses-Flores, Cesar Luna-Rivero, Jose Sullivan Lopez-Gonzalez
Published 2020-11-01
Article -
2
-
3
Glycine by enteral route does not improve major clinical outcomes in severe COVID-19: a randomized clinical pilot trial by Mario H. Vargas, Jaime Chávez, Rosangela Del-Razo-Rodríguez, Carolina Muñoz-Perea, Karina Julieta Romo-Domínguez, Renata Báez-Saldaña, Uriel Rumbo-Nava, Selene Guerrero-Zúñiga
Published 2024-05-01
Article -
4
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment by Dolores Aguilar-Cazares, Rodolfo Chavez-Dominguez, Rodolfo Chavez-Dominguez, Mario Marroquin-Muciño, Mario Marroquin-Muciño, Mario Perez-Medina, Mario Perez-Medina, Jesus J. Benito-Lopez, Jesus J. Benito-Lopez, Angel Camarena, Uriel Rumbo-Nava, Jose S. Lopez-Gonzalez
Published 2022-08-01
Article -
5
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines by Rodolfo L. Chavez-Dominguez, Rodolfo L. Chavez-Dominguez, Mario A. Perez-Medina, Mario A. Perez-Medina, Jose S. Lopez-Gonzalez, Miriam Galicia-Velasco, Margarita Matias-Florentino, Santiago Avila-Rios, Uriel Rumbo-Nava, Alfonso Salgado-Aguayo, Claudia Gonzalez-Gonzalez, Dolores Aguilar-Cazares
Published 2021-12-01
Article